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ABSTRACT
Restless Legs Syndrome (RLS) is a disorder characterized by
disagreeable leg sensations, usually prior to sleep onset, which
cause an almost irresistible urge to move the legs.

A

characteristic feature of this disorder is that the movements
are partially or completely relieved with leg motions.

Attempts

to find the underlying pathology have been unsuccessful.

Thus,

there are no objective physiological tests to diagnose this
condition.

Using the Suggested Immobilization Test (SIT), the

current study attempted to validate a new and practical method
for quantifying the motor symptoms of RLS, actigraphy.

To this

end, the SIT with actigraphy was evaluated for its usefulness as
either a diagnostic or screening tool using indices of
sensitivity, specificity, false positive and false negative
rates, taking base rates into account.

The actigraphic SIT was

not found to be an effective diagnostic or screening tool.
Further advancements in actigraph technology and future research
may eventually provide evidence of an actigraphic SIT being an
effective screening or diagnostic tool, despite the findings in
the present study.
encountered.

Limitations in actigraph technology were

These limitations are described, as well as the

implications for the current study and similar existing
research.

v

INTRODUCTION
Restless Legs Syndrome (RLS) is a disorder characterized by
disagreeable leg sensations, usually prior to sleep onset, which
cause an almost irresistible urge to move the legs.

A

characteristic feature of this disorder is that the movements
are partially or completely relieved with leg motions.

Attempts

to find the underlying pathology of RLS have been unsuccessful.
Thus, there are no objective pathophysiological assessments to
diagnose this condition.

The diagnosis of RLS remains a

clinical one based on the patient’s self-report of symptoms.
Identifying any objective means of quantifying RLS
symptomatology could be used diagnostically and aid in research
of RLS.

Objective testing could provide for development of

objective screening tests or aid in comparing participant
characteristics in research studies.
Ongoing research is attempting to develop objective tests
of RLS symptoms.

To that end, two tests have been developed to

measure the motor restlessness experienced by RLS patients, the
Suggested Immobilization Test (SIT) and the Forced
Immobilization Test (FIT).

The ability to use these tests both

clinically and for research purposes is somewhat limited by the
specialized equipment and staff time/resources needed to perform
these.

Thus, the current study aimed to validate a new and more

practical method for quantifying the motor symptoms of RLS,
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actigraphy.

Additionally, whether or not the SIT or the FIT has

adequate sensitivity and specificity to discriminate between RLS
and normal individuals has proved debatable.

To this end, the

current study aimed to evaluate the SIT with actigraphy using
indices of positive and negative predictive values, taking base
rates into account.
First, characteristics of RLS identified in research and
clinical samples will be described in detail and related to
current diagnostic criteria.

Features and conditions associated

with RLS will be described.

Then, actigraphy will be discussed,

with particular emphasis on how this methodology is applicable
to the assessment of RLS symptoms.

Next, specific research

findings pertinent to the current study will be described.
Last, the methodology and findings from the current study are
detailed.
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REVIEW OF LITERATURE
Clinical Features
Restless Legs Syndrome (RLS), as defined by the ASDA (ASDA,
1990), is a disorder characterized by disagreeable leg
sensations, usually prior to sleep onset, that cause an almost
irresistible urge to move the legs.

The ASDA delineates six

diagnostic criteria for RLS, the first three of which are
necessary for a diagnosis.

The criteria are: (1) a complaint of

an unpleasant sensation in the legs at night or difficulty in
initiating sleep; (2) disagreeable sensations of “creeping”
inside the calves often associated with general aches and pains
in the legs; (3) the discomfort is relieved by movement of the
legs; (4) polysomnographic monitoring demonstrates leg movements
at sleep onset; (5) no evidence of any medical or psychiatric
disorders that account for the leg movements; (6) other sleep
disorders may be present but do not account for the symptom.
The ASDA categorizes severity into three categories.

Mild

refers to symptoms that occur episodically with no more than a
mild disruption of sleep onset that does not cause the patient
significant distress.

Moderate RLS refers to symptoms that

occur less than twice a week, with a significant delay of sleep
onset, moderate disruption of sleep and mild impairment of
daytime function.

In severe RLS, the symptoms occur three or

more times a week, with severe disruption of nighttime sleep
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patterns and marked daytime symptoms.

Also, duration criteria

are delineated: acute (two weeks or less), subacute (more than
two weeks but less than three months) and chronic (three months
or longer).
RLS patients often have difficulty describing the nature of
the uncomfortable sensations.

Some terms most often used by

patients to describe the sensations include “creeping”,
“crawling”, “itching”, “tingling”, “prickling”, or “pins and
needles” (ASDA, 1990; Ekbom, 1960; Walters & Hening, 1987).
Researchers often use the term paresthesias or dysesthesias,
which simply imply abnormal sensations.

These uncomfortable

sensations develop or are exacerbated during periods of motor
inactivity and are relieved by agitated motor activity.

For

many RLS patients, sleep onset is particularly difficult to
attain due to the increase in symptoms and symptom severity
associated with lying still in bed, such that they may have to
get out of bed and walk to relieve their discomfort.

Pelletier,

Lorraine and Montplaisir (1992) studied whether the motor
movements exhibited were a direct consequence of the
uncomfortable sensory events by examining the temporal
relationship between these events.

These researchers found that

while almost all of the sensory events were associated with leg
movements, determined by a sensory event occurring either 5
seconds before or after the leg movement, there were some
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sensory events without motor events.

Additionally, only half

(49%) of the motor symptoms were associated with sensory events,
indicating that some were not in an effort to relieve
discomfort.

Thus, the authors concluded that the sensory and

motor events in RLS represent independent manifestations of a
common neural dysfunction.
RLS symptoms have been found to be worse in the evening or
at night, and worse when lying or sitting during the day or the
night (Ekbomb, 1946; Ekbomb, 1960).

Part of this worsening

appears to be due to the fact that people tend to sit and lie
down more in the evening hours than during the day.

However,

there is also evidence for an independent circadian factor
contributing to the nighttime worsening (Montplaisir, Boucher,
Gosselin, Gaetan, & LaVigne, 1995; Trenkwalder, et al., 1995).
Research examining this feature of RLS is discussed later in the
current paper.
Another characteristic of RLS relevant to the current study
is the degree of lateralization of symptoms.

Historically, most

patients have been reported as having bilateral sensory and
movement symptoms.

Montplaiser et al. (1997) found that forty-

two percent of patients reported at least some lateralization of
sensory and motor symptoms to either the right or the left leg.
Additionally, Montplaiser et al. (1998) found that movements
were predominantly bilateral (mean index of bilateral
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movements=52/hour), though there were a number of movements
exhibited exclusively on the right leg only (mean index=14/hour)
or on the left leg only (mean index=10/hour).

Of the sixteen

RLS patients who participated in their study, there was one RLS
patient for whom the movements were predominantly or exclusively
exhibited on the right and one whose movements were such on the
left.

Thus, the above findings confirm that many patients have

predominantly bilateral movements; however, some patients do
have some lateralized movements and some patients have
predominantly lateralized movements.
Associated Features and Conditions
Prevalence.

Ekbom (1945) first estimated the prevalence of RLS

in the normal population as being 5%.

Across studies, the

prevalence of RLS in the general population has been estimated
to be from 2-15%; however, definitive data are not available
(ASDA, 1990).

Much of the variability in the rates described is

due to vast differences in methodology employed, from face-toface interviewing performed by trained professionals (Rothdach,
Trenkwalder, Haberstock, Keil, Berger, 2000) to a single RLS
question added to a survey of multiple phenomena (Phillips et
al., 2000).

Most studies have found rates of approximately five

percent.
Age of Onset.

To date there have been no longitudinal studies

performed to definitively identify the typical age or age range
6

in which RLS develops.

Thus, most studies reporting age of

onset in RLS are based on retrospective self-report.

Not

surprisingly, vast differences reported in the literature
concerning the age of onset of RLS have been largely due to
methodological differences.

RLS has typically been considered

to be a disorder of the middle to older age population.
However, some studies have suggested that this is inaccurate.
RLS patients in a study by Ondo and Jankovic (1996) reported an
average age of onset of 34 years, though there was a high degree
of variability (standard deviation of 20.3).

In another study

(Walters et al., 1996), more than one third of the RLS patients
reported experiencing their first symptoms before the age of 10,
and 43% had their first symptoms before the age of 20.

These

findings suggest that RLS may not be predominantly a disorder of
middle age, but a condition that has a much earlier onset than
previously identified.

One hypothesis suggested for this

discrepancy is that young persons with the RLS symptoms are
initially misdiagnosed as experiencing “growing pains” or the
symptoms were thought to by psychogenic (Walters et al., 1996).
Additionally, given that the symptoms have often been found to
increase in severity with age for many individuals, it is
possible that RLS is present, but not diagnosed, in younger
individuals who may not present for treatment until the symptoms
become severe.
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Clinical Course.

RLS symptoms can have a varied course, with

some patients reporting that the symptoms increase over time and
others reporting a constant degree of symptom severity.
patients report that symptoms remit occasionally.

Many

In a

questionnaire study of 138 patients with RLS (Walters et al.,
1996), 15% of the patients reported a previous total remission
of symptoms of a month or more.

Thus, the symptoms may have a

waxing and waning course, though there have been no findings to
explain this information.
Associated Conditions.

Attempts to find biological markers

have yet to be successful.

Although there have been

abnormalities identified in some subsets of persons with RLS,
the sensitivity and the specificity of these has not been
sufficient for their usefulness as diagnostic markers.

RLS has

been found to exist at higher than normal rates in a number of
medical conditions: 11% of pregnant women, 15-20% of uremic
patients, and up to 30% of patients with rheumatoid arthritis
(ASDA, 1990).

RLS has often been associated with another,

related condition, namely periodic limb movement disorder
(PLMD).

In one study, approximately 80% of RLS patients had co-

morbid PLMD (Montplaisir et al., 1997).

Individuals for whom

there is no identifiable medical cause of this symptom are
referred to as having primary or idiopathic RLS.

Individuals

reporting symptoms of RLS, but with an identified cause are
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generally referred to as having secondary RLS.

There do not

appear to be any differences in symptom presentation between the
primary and secondary forms of the disorder (Walters, 1995).
Periodicity of Movements while Awake
One difficulty often encountered in the literature on RLS
is that the ASDA criteria do not adequately describe the motor
symptoms of this disorder.

The lack of adequate descriptive

criteria has led to inconsistent usage of the diagnosis.

For

example, some researchers have utilized the term RLS as if it
were a symptom or form of PLMD.

This stems from previous

beliefs that RLS always occurred in conjunction with PLMD, and
that a diagnosis of PLMD would support a diagnosis of RLS; a
PLMS index greater than five or ten has been previously used by
some as an “objective diagnostic criterion” of RLS (Walters,
Picchietti, Ehrenberg, Wagner, 1994).

Given the frequency this

association occurs in the RLS literature, a brief review of the
clinical characteristics of PLMD is warranted to highlight the
similarities and differences in these overlapping disorders and
patient populations.
Some researchers have used the terms PLMD interchangeably
with periodic limb movements of sleep (PLMS).

Other researchers

have used PLMD to refer exclusively to patients meeting the
diagnostic criteria set forth by the ASDA, and used PLMS to
refer to the repetitive limb movements that occur during sleep
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in some individuals without necessarily meeting the diagnostic
criteria.

For the purposes of this paper, PLMD will refer only

to those individuals meeting diagnostic criteria for the
disorder and PLMS will refer to any movements occurring during
sleep that conform to scoring criteria for periodic limb
movements (i.e., as opposed to non-periodic movement activity),
both of which are described in greater detail below.
PLMD is characterized by periodic episodes of repetitive
and highly stereotyped movements that occur during sleep at a
rate of five per hour or greater (i.e., PLMS).

In PLMD, the

movements do not occur during the day and persons with PLMD may
or may not experience any daytime symptoms, such as
hypersomnolence.

Coleman’s criteria (Coleman, 1982) have become

standard for defining and scoring PLMS.

The criteria allow for

scoring a limb movement as a PLMS when it occurs as a part of a
series of at least four consecutive movements that are separated
by at least 4, but not more than 90 seconds.

Additionally, the

duration of the movement must be between 0.5 and 5.0 seconds.

A

PLMS index refers to the average number of PLMS per hour of
sleep, with an index of more than 5 per hour being pathological
and qualifying for a PLMD diagnosis.
Researchers and clinicians, who have conceptualized RLS as
being a symptom or form of PLMD, postulate that not all persons
with PLMD have RLS, but that all RLS patients have PLMD.
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However, research in these populations has documented that while
many patients with RLS do indeed have PLMS, many do not show
evidence of PLMD or do not have sufficient PLMS to warrant a
diagnosis of PLMD (ASDA, 1990).

For example, Montplaiser et al.

(1997) found that of 133 patients diagnosed with RLS, 20% had
PLMS index lower than 5 (i.e., PLMS index in the normal range).
Thus, the PLMS index alone would not be either necessary or
sufficient to diagnose RLS in patients complaining of sensory
and motor symptoms associated with periods of inactivity.

PLMD

represents a nosological and clinical entity that can be
differentiated from RLS; though these conditions are often
overlapping, RLS is primarily a problem experienced during
wakefulness just prior to sleep onset, while PLMD is primarily a
phenomenon occurring during sleep.
As described, the predominant symptoms in RLS occur during
wakefulness.

Involuntary movements similar to PLMS have been

reported to exist during wakefulness in RLS patients (Brodeur,
Montplaisir, Godbout, Marinier, 1988; Montplaisir, Godbout,
Boghen, De Champlain, Young, 1985; Montplaisir & Godbout, 1989;
Pelliter, Lorrain, & Montplaisir, 1992).
PLMD are highly stereotyped movements.

The movements seen in

One similarity between

PLMS and the involuntary movements seen in RLS patients is that
they are similar in appearance.

Specifically, the movements are

typically dorsiflexions of the big toe with fanning of the small
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toes, accompanied by flexions of the ankles, knees and thighs.
PLMS are, by definition, periodic, but the movements exhibited
by RLS patients may be either periodic (Pollmacher & Schulz,
1993; Walters et al., 1988) or aperiodic (Walters, 1995).

The

involuntary movements while awake occur almost exclusively at
rest and cease with activity.

Moreover, PLMS are rarely rapid

enough to be considered myoclonic, while the involuntary
movements seen in waking RLS patients can be myoclonic, though
they are often more sustained than PLMS (ASDA, 1990).

Last,

many of the movements in RLS are voluntary movements intended to
alleviate paresthesias.

Thus, the movements in RLS both during

wakefulness seem to be both voluntary and involuntary.
Relevant Research Findings
In response to an evident inconsistency in the definition
of RLS, a large international study group was formed and
identified essential criteria for the diagnosis of RLS.

The

study group noted that the ASDA criteria do not adequately
characterize the motor restlessness in RLS or the involuntary
motor movements evidenced in RLS patients during periods of
wakefulness (Walters, 1995).

The group delineated four minimal

clinical characteristics necessary for the diagnosis: (1) a
desire to move the limbs, usually associated with
paresthesia/dysesthesias; (2) motor restlessness (i.e., use of
various motor activities to relieve the discomfort); (3)
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symptoms that are worse or exclusively present at rest (e.g.,
lying, sitting) with at least partial and temporary relief by
activity; (4) symptoms that are worse in the evening or at
night.

Several other clinical features were identified that are

commonly seen in RLS patients, though they are not necessary for
the diagnosis: (1) sleep disturbances and its consequences; (2)
involuntary movements which could refer to periodic limb or leg
movements in sleep or involuntary leg movements while awake and
at rest; (3) no neurological abnormalities in the primary form,
though these may be present in the secondary form; (4) the
clinical course is variable, but most of the more severely
affected patients are middle to older age, and the condition is
progressive; (5) a familial pattern may be present.
Researchers (Brodeur et al., 1988; Pelletier, Lorrain,
Montplaisir, 1992) attempting to quantify the motor symptoms in
RLS designed two tests, the Forced Immobilization Test (FIT) and
the Suggested Immobilization Test (SIT).

For the SIT test,

patients sit or lie motionless on a bed with their legs
outstretched and eyes closed while electromyogram recordings of
the anterior tibialis muscles are recorded bilaterally.

This

test was first employed in 1988 to measure the therapeutic
effects of L-dopa in RLS patients (Brodeur et al., 1988).

The

FIT employs greater leg immobilization, where the patient sits
on a stretcher with both legs immobilized in the extended
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position.

The stretcher prevents movement of the legs and

limits the movement of the ankle and the foot.
Montplaisir et al. (1998) examined the sensitivity and
specificity of the SIT and the FIT in differentiating sixteen
RLS patients from sixteen age- and sex- matched control
subjects.

RLS patients had three times more leg movements

during the SIT than did normal controls, with a mean of 76 for
RLS patient versus 27 for controls.

Additionally, both RLS

patients and controls evidenced more movements during the second
half of the hour-long test, but the difference was significant
only in the RLS patients.

On the FIT, RLS patients did have

more movements than controls, but the difference was
statistically significant only when comparing each group on the
second half of the test; the differences between the two groups
on the first half of the test and on the entire test were not
statistically significant.

Using receiver-operator

characteristic curves to obtain cutoff scores, Dawson-Saunders &
Trapp (1994) suggested that a cutoff of 40 movements per hour on
the SIT or of 25 movements on the FIT resulted in the highest
overall sensitivity and specificity of the two tests.

The SIT

proved to differentiate between the RLS patients and the
controls better than the FIT, with a sensitivity of 81% and a
specificity of 81%, compared to 69% and 56%, respectively, for
the FIT.

The authors posit that the movements exhibited during
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the SIT may represent combinations of different types of
movements, both involuntary periodic leg movements and voluntary
movements to relieve discomfort, and that during the FIT the
voluntary movements are decreased due to external leg
restraints; also, the decreased movement may not have allowed
for as much relief from discomfort and that the patients may
have not moved as much as a result.

However, they provide no

evidence to support this claim.
Two explanations of the finding that RLS symptoms are worse
in the evening and at night are that either a circadian factor
modulating these symptoms exists, or that people tend to lay
down more in the evening and night time hours, or a combination
of the two.

To examine these hypotheses, Montplaiser et al.

(1995) conducted a study to examine sensory symptoms and motor
symptoms in the morning and evening in RLS patients.

The

researchers utilized the SIT to measure motor symptoms, and
required the patients to press a button each time they
experienced a paresthesia in their legs similar to those
experienced at home, to assess subjective sensory symptoms.

The

SITs were performed once in the morning and again in the
evening, with the evening SIT being lengthened from thirty
minutes to an hour to examine the role that immobility duration
plays in the severity of motor and sensory symptoms.

The

results indicated that the duration of the immobility did result
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in a statistically significant exacerbation of both motor and
sensory symptoms.

However, neither the sensory nor motor

symptoms were statistically greater during the evening than the
morning SIT.

The data suggest that time of day effects may not

be important in differentiating RLS patients from normal
controls in relation to motor restlessness, but that it would be
useful to increase the duration of the SIT recording from 30 to
60 minutes.
Researchers utilizing the SIT to measure daytime motor
restlessness in RLS patients have often used Coleman’s PLMS
criteria to score movements.

One alteration often employed in

daytime SIT recording is extending the upper duration limit of
the movement to 10 seconds because a large number of movements
during wakefulness exceed 5 seconds (Montplaisir et al., 1998).
However, it is unclear how appropriate this methodology is given
that not all movements by RLS patients are involuntary or
periodic.

Further, it is unknown how the use of PLM criteria to

score movements affects the sensitivity and specificity of the
SIT.
Sleep laboratories rely on a patient’s self-report of
symptoms to diagnose RLS.

Currently, the only objective

measures of motor symptoms experienced by persons with RLS are
the SIT and the FIT.

Prior research on the sensitivity and

specificity indicates that the SIT has greater promise as an
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objective means of differentiating normal subjects from
individuals with RLS.

However, the SIT tests require

considerable staff time to perform and analyze results.

The

latter problem also impedes the ability of researchers to
explore ways to increase the sensitivity and specificity of the
SIT.

Thus, there is a need for an objective measure of RLS that

could be completed with minimal staff involvement and/or without
the use of specialized staff.

The current study attempted to

evaluate the appropriateness of using actigraphy instead of a
polygraph to complete a SIT test and examined factors
potentially related to the ability of the SIT to objectively
differentiate RLS patients from control subjects (i.e., persons
without RLS or other movement disorders).

This novel method for

examining RLS, if validated, could allow for long-term night-tonight quantification of RLS symptomatology, a task that is not
feasible with standard polysomnography.
Actigraphy
The current study proposed to validate the use of
actigraphy to examine RLS motor symptoms.

Actigraphs are small,

portable devices that detect physical motion, generate an
internal signal each time they are moved, and store that
information.

They are typically used to measure general or

random motor restlessness in order to evaluate rest-activity
cycles.

Actigraph recordings integrate the amplitude values of
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an actigraphic signal over a defined time period, usually 10, 30
or 60 seconds, and algorithms can be used to estimate the sleep
architecture of an individual.

The user can set the frequency

desired for integrating the amplitude values of the signal to
produce output from every 2 to every 60 seconds.
In the area of sleep and sleep disorders, actigraphy is
typically used to estimate sleep onset and duration based on the
relative lack of movement activity during sleep.

Actigraphy has

been shown to best estimate sleep duration, sleep efficiency and
waking after sleep onset; it is less accurate at estimating
sleep onset latency (ASDA Report, 1995).

Research evaluating

the usefulness and validity of actigraphy in RLS and PLMD
patients, other movement disorders, or insomnia indicates that
actigraphy provides a poor estimate of sleep parameters.

In all

of the latter conditions, the patient may be having movements
while asleep, or may be still while lying awake for a prolonged
period of time, thereby inaccurately estimating sleep.

However,

while actigraphy is poor in evaluating the sleep of these
patient populations, it is not poor at detecting movement.
Actigraphy provides a measure of general motor activity,
and may not accurately measure short, distinctive movements like
PLMS.

In 1995, Kazenwadel et al. studied the reliability and

validity of using actigraphy to measure periodic limb movements.
The results showed that there was a high correlation (.91)
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between the EMG recording and the actigraph recordings, but
actigraphy did underestimate the number of PLMS, with the
actigraph recording 30% fewer movements than were identified by
EMG recordings.

However, one difference between these two

methodologies may explain the underestimation of PLM activity by
actigraphy: Recordings of tibialis electromyogram monitor
movements made by either leg independently or by both legs
simultaneously, but the study employed the use of one actigraph
placed on one leg, which is the methodology typically employed
in actigraphy.

The underestimation of PLM activity by the

actigraphs may have been due to the use of one actigraph on one
leg, which may not have been detected unilateral movements on
the leg opposite the actigraph.

Therefore, this investigation

did not adequately assess the sensitivity of actigraphy as a
measure of PLMS.

No investigation to date has attempted to

evaluate actigraphy as a measure of RLS movements.
Study Objectives
The goals and implications for the current study were as
follows.

First, validate the use of actigraphy to objectively

quantify motor restlessness in RLS, using the actigraphy and the
polygraph simultaneously.

Second, determine whether or not

using PLM criteria to score movements results in significant
differences in the number of movements identified during the
SIT.

Third, determine whether or not it would be advantageous
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to use bilateral actigraphs rather than unilateral to
approximate polygraph recordings of leg movements.

Fourth,

evaluate the ability of the SIT to differentiate between normal
subjects and persons with RLS.

It was hoped that the results

from the above analyses would provide support for an actigraphic
SIT test to identify persons with RLS.
If the actigraphic SIT test was capable of differentiating
between RLS and normal subjects, this methodology could be used
as a large-scale screening tool and as a means of longitudinal
follow-up in sleep medicine research and in clinical sleep
medicine.

Serial SIT tests would be useful for objectively

assessing symptom variability across time in the RLS population,
which is currently not feasible with the use of polygraphic SIT
tests.

In the following section, the methodology and statistics

that were used to test these experimental questions are
described.

20

METHODS
Participants
Fifteen subjects for each group, RLS and controls, were
recruited to participate, for a total of thirty subjects.

RLS

subjects were volunteers recruited through the Ochsner Clinic of
Baton Rouge Sleep Disorders Center, through contacts with the
Restless Legs Foundation and a local support group leader.

RLS

subjects were not excluded if they had another sleep disorder,
given that having another sleep pathology would not affect a
daytime recording or motor activity.

Any RLS subjects being

treated for RLS or PLMD with medications would have been asked
to abstain from taking any medications related to their RLS on
the day of the study; however, none of the participants were
taking medications at the time of the study.

Since there is no

difference in the symptom presentation of primary and secondary
RLS, conditions known to cause RLS were not ruled out.

The

latter differentiation would be more important in determining
the appropriate treatment, rather than integral in identifying
individuals with symptomatology consistent with RLS.
The control group subjects were selected such that they
would not be significantly different in age from the RLS group,
to control for possible age-related effects.

An ANOVA comparing

the average age of the participants in the RLS group versus the
control group showed that the two groups were not significantly
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different in age (F [1,28] =.001, p = .971).

See Table 1 for

descriptive statistics by group.
Table 1.
RLS
Controls

Age of Participants by Group
Mean (years)
51.73
51.93

Standard Deviation
14.76
14.99

Control subjects were recruited from older undergraduate
students at Louisiana State University, family members of
younger undergraduates enrolled in psychology classes, and from
age-similar associates of RLS group subjects.

Students who

recruited a participant received extra credit towards psychology
classes for their participation, but other subjects were not
directly compensated for their participation.
Basic demographic data was collected.

Tables 2-8 provide

the results of information obtained from the questionnaire
(shown in Appendix C) completed by the participants.
The genders were equally distributed in the RLS group, with
males accounting for 47% of the participant and females
accounting for 53% of the participants.

The majority of the

participants in the control group were female (87%).
whole, the participants were largely female (70%).

As a

The majority

of the RLS participants (80%) did not report any lateralization
of symptoms (see Table 3).

Three RLS participants (20%)
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reported that their symptoms were worse on the right side of
their body.

Table 2.

RLS
Controls
Total

Gender of Participants by Group

Male
Frequency
Percent
7
47%
2
13%
9
30%

Table 3.

Female
Frequency
Percent
8
53%
13
87%
21
70%

Lateralization of Symptoms

Activity
No lateralization
Symptoms worse on the left side
Symptoms worse on the right side

Frequency
12
0
3

Percent
80%
-20%

The majority of the RLS participants indicated that the
following activities provide relief from their symptoms: moving
the legs (93%), getting up and walking around (87%), stretching
the legs (80%), rubbing or massaging the legs (73%).

Few people

reported obtaining relief from either using a heating pad/taking
a warm bath (27%) or from applying anything cold to the legs
(17%).

The reported location of the sensations was consistent

with clinical descriptions.

Specifically, the majority of RLS

participants experience symptoms in the legs (87%) and/or their
thighs (87%).

For a detailed listing of the locations of

symptomatology reported, see Table 5.
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Table 4.

Proportion of RLS Subjects Indicating the Specified
Activity Provides Relief

Activity
Rubbing or massaging the legs
Moving the legs
Using a heating pad or taking a warm bath
Applying anything cold to the legs
Stretching the legs
Getting up and walking around
Table 5.

Frequency
11
14
4
2
12
13

Percent
73%
93%
27%
13%
80%
87%

Location of Sensations

Activity
Feet
Lower legs (between the ankle and the knees)
Thighs
Groin
Trunk
Shoulders or neck
Upper arms
Forearms
Hands or fingers

Frequency
10
13
13
2
2
7
4
2
4

Percent
67%
87%
87%
13%
13%
47%
27%
13%
27%

Results of questions pertaining to freq uency of sensations
over the past 6 months illustrated the range of symptom severity
in the RLS participants (see Table 6 and 7).

Four of the

participants (27%) indicated experiencing their symptoms
exclusively at night.

Only one participant (7%) reported having

symptoms every day and one (7%) having symptoms every night.
Table 6.

Frequency of Sensations in Legs at Night Over the Past
6 Months

Activity
One or two nights a week
Three or four nights a week
Five or six nights a week
Every night of the week

Frequency
3
7
4
1
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Percent
20%
47%
27%
7%

Table 7.

Frequency of Sensations in Legs During the Daytime
Over the Past 6 Months

Activity
One or two days a week
Three or four days a week
Five or six days a week
Every day of the week

Frequency
4
5
1
1

Percent
36%
46%
9%
9%

All of the RLS participants reported that physical activity
relieves their symptoms and that their symptoms get worse in the
evening.

Table 8 shows that the majority (80%) of RLS

participants have difficulty falling asleep because of their
symptoms.

Some of the participants indicated performing a

physical regimen prior to attempting sleep to keep from having
sleep onset difficulties.

Half (53%) of the participants

reported that their symptoms are worse when they are under
stress.

Only five of the participants (33%) had previously

sought treatment for their symptoms.

Of those who had sought

treatment, only one was properly diagnosed with RLS.

Half of

the participants (53%) had been evaluated by a sleep center
prior to participation in the current study.
Since many persons with RLS report an increase in symptoms
in the evening, attempts were made to have subjects participate
in the late afternoon or early evening hours.

The late

afternoon/evening time was preferred because of the probable
increase in symptom severity in the evening, which could
increase the probability of differentiating between
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Table 8.

Other Descriptive Questions
Yes
Frequency Percent

Question
Do your symptoms get
worse in the evening or
night?
Does physical activity
decrease or relieve your
symptoms?
Are your symptoms worse
when you are under
stress?
Do you have difficulty
falling asleep because
of your symptoms?
Have you ever sought
treatment for your
symptoms of restless
legs?
Have you ever had a
sleep study?

controls and RLS subjects.
circadian factors.

No
Frequency Percent

15

100%

0

--

15

100%

0

--

8

53%

7

47%

12

80%

3

20%

5

33%

10

66%

8

53%

7

47%

It also controls for possible

Attempts were made to have equal numbers of

subjects from both groups participate in the same time periods.
The number of subjects from each group who participated anytime
before noon versus afternoon/evening is detailed in Table 9.

Table 9.

RLS
Controls
Total

Participation Times of Participants by Group
A.M.
Frequency
Percent
4
13%
7
23%
11
37%
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P.M.
Frequency
Percent
11
37%
8
27%
19
63%

Measuring Movement Activity
The SIT tests were conducted at the Sleep Laboratory,
Department of Psychology, Louisiana State University.

Subjects

were instructed to stay awake, sit on a bed with their legs
outstretched, and to keep their eyes open while attempting to
remain completely still for 60 minutes.

Movement activity

during the SITs was recorded on a Bio-Logic Systems Sleepscan
computerized polysomnograph, which recorded anterior tibialis
electromyogram (EMG) activity from both legs.

The EMG was

recorded using Grass Instruments 10 mm gold-cup electrodes and
conformed to standard electrode site placement (ASDA Atlas Task
Force, 1993).
Two ActiTrac actigraphs were used for each subject, with
one being placed on the ankle of each leg.
occurred simultaneously for 60 minutes.

Both recordings

The ActiTrac monitor

contains a piezoelectric sensor to record physical motion.

The

acceleration signal produced by body motion is sampled at a rate
of 40 times per second and is digitally integrated to measure
movement activity.

This activity is converted to data counts

and is accumulated for each time epoch and stored in memory.
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Experimental Hypotheses
The following experimental hypotheses were tested:
1.

It was hypothesized that the actigraph could validly
identify and quantify leg motor activity, as defined by
anterior tibialis EMG.

2.

It was hypothesized that RLS subjects would have
significantly more leg movements than control subjects on
the SIT, as defined by both anterior tibialis EMG and
actigraphy.

3.

It was hypothesized that the actigraphic SIT is a valid and
effective test (as defined by Gouvier, Hayes, Smiroldo, 1998
discussed in Part II of the Test of Experimental Hypotheses
section) of RLS above base rates.
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RESULTS
Preliminary Analyses
Pilot Testing of Actigraph Reliability.

To test the reliability

of the actigraph recordings, a one-hour pilot testing recording
was conducted on a single subject using three actigraphs
simultaneously.

Two actigraphs were placed on the left ankle

and one actigraph on the right ankle.

Three Kappa correlations

were performed to examine the exact agreement between the
actigraphs.

The results are shown in Table 10.

All Kappa

statistics were significant, indicating that the actitracs were
reliably recording the same movements.

The pilot test was

conducted with a single subject; as such, the findings may be
subject to bias.

Had additional subjects been employed, a wider

range of movements may have tested the acitgraphs further and
led to earlier identification of the recording delay discussed
later.
Table 10.

Kappa Statistics for Pilot Actitrac Recordings

Left Actitrac 1: Left Actitrac 2
Left Actitrac 1: Right Actitrac
Left Actitrac 2: Right Actitrac

Kappa
.844
.770
.858

Sig.
<.001
<.001
<.001

Evaluating the Utility of Using PLM Criteria to Score Movement
Activity.

Researchers have been inconsistent in whether or not

PLM criteria were used to score movements during the SIT.
Clinical descriptions of RLS and RLS research indicate that the
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leg movements experienced by RLS patients during the day are
both voluntary (i.e., movements deliberately initiated by the
patient to alleviate sensory events) and involuntary.

Both

kinds of movements have shown some evidence of periodicity.

It

is possible that given the uncomfortable sensations commonly
experience by those with RLS, that they would also perform a
greater number of voluntary movements to relieve the discomfort
than controls who do not experience this added discomfort. Thus,
quantifying all movements may provide for larger differences
between groups, and therefore better discrimination, as opposed
to only using those movements meeting PLM criteria.

To examine

this, a paired sample t-test was computed to compare the number
of movements that conform to PLM criteria versus the total
number of movements for both groups of subjects based on
tibialis EMG.

Table 11 shows the average number of movements

identified by type.

Analyses showed that significantly more

movements were identified when all movements were counted (t[29]
= 6.62, p<.001); however, it was observed in the current study
that the ratio of movement activity between the groups was
greater for PLM movements than for total movements.

In other

words, while the average total movements for the RLS
participants (37 movements/hour) was about three times greater
than the average for the controls (13 movements/hour), the
average PLMs for the RLS participants (17 PLMs/hour) was about
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six times greater than the average for the controls (3
PLMs/hour).

Thus, it is possible that using only the PLMs could

in fact prove a better discriminator, and therefore a better
classification measure, than using all movement activity.
Analyses reported later highlight that there is actually no
benefit, or deficiency as initially suspected, in the practice
of counting only PLM activity.

As it made no difference which

outcome measure was chosen, subsequent analyses are based on the
more comprehensive measure (i.e., all movement activity),
regardless of periodicity.

Table 11.

Average Number of Movements by Group*

Number of PLMs Other Movements All Movements
Mean
s.d.
Mean
s.d.
Mean
s.d.
RLS
16.7
24.9
20.0
14.5
36.7
37.4
Control
3.0
4.9
9.7
6.6
12.7
10.4
Total
9.8
18.9
14.8
12.3
24.7
29.6
*Based on EMG Recording
Comparing the Use of One Actigraph versus Two.

For the three

RLS subjects reporting either some or predominantly lateralized
symptoms, scoring of movement based on a single actigraph
utilized the data collected on the side the individual reported
as the source of the greatest degree of symptomatology.

For all

control subjects and RLS participants not reporting symptom
lateralization, single actigraph scoring of movement was based
on the recording from the left leg.
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To score the number of

movements identified on both actigraphs, a movement was counted
if it occurred on either leg or both legs.
The recording interval or epoch length (i.e., the amount of
time represented by a data point) can be set to increments
ranging from 2-seconds to 30-second epochs.

Thus, while the

actigraph samples 40 times per second, the most frequent
recording epoch is 2-seconds.
in the current study.

The 2-second epoch was utilized

Additionally, the output from the

actigraph can be viewed as a bar graph (as illustrated in Figure
1) or can be exported to a Microsoft Excel worksheet (see
partial sample output in Table 12).

A zero would indicate no

movement activity and any number other than zero would indicate
that movement occurred in the specified time period.

This

approach was taken simply to make computing frequency counts
possible.

If the raw numbers were employed, computing frequency

counts in SPSS would have been meaningless, as all numbers would
have been treated as a unique entity and become categories of
activity that would be counted as often that specific number
occurred.

Thus, to compute frequency counts, all output was

dichotomized, with zeros indicating no movement activity and all
other numbers being converted to ones to indicate movement
activity.

To allow for comparisons in the current study, all

actigraph results were first exported to a Microsoft Excel
worksheet.
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It was hypothesized that if some movements in the
Kazenwadel et al. study were missed due to the use of a single
actigraph, the use of two actigraphs might have more closely
approximated the polygraph recordings of leg movements.

In

the

Figure 1.

Sample Actitrac Bar Graph Output

present study, the total number of 2-second epochs with movement
recorded during the SIT for each group was computed, using the
results from one actigraph compared to results from both
actigraphs.

A paired sample t-test was conducted.

The analyses

indicated that significantly more movements were identified by
the use of two actigraphs than one actigraph (t[29] = -3.7, p =
.001).

However, in examining the data closely, these results

were found to be misleading.
The actigraphs did appear to be capturing the same movement
activity, though not at exactly the same time.

Table 12 shows

one example of the raw output from the left and right leg
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recording from one of the subjects.

Table 13 provides sample

recoded output obtained from the left and right ActiTrac from a
subject that had two movements, and illustrates the coding of
activity based on both actigraphs.

Both the left and the right

actigraphs recorded four 2-second epochs with movement activity,
with each movement represented by two 2-second epochs.

However,

in the example shown, the right actigraph is clearly “delayed”
in logging the movement compared to the left actigraph.

Thus,

while both actigraphs were properly logging movement activity,
they were not logging the same movement at the exact same point
in time according to the output.

This lack of synchronization

in timing results in overestimating movement activity when
recoding the information to quantify activity from both
actitracs.
It should be stated that the delay was clearly not
attributable to any true delay in movement activity between one
leg and the other leg.

In other words, it was not possible that

the delay identified was due to a participant moving one leg and
later moving the other leg.

The identified delays were

consistent within a participant’s recording.

The partial sample

output in Table 12 illustrates two successive movements on each
leg, with the “movement” on the right leg appearing eight
seconds later than the left.

If the whole output were shown,

one would see that every time movement activity occurred on the
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Table 12.

Sample Actigraph Output in Microsoft Excel

Time
6:23:54
6:23:56
6:23:58
6:24:00
6:24:02
6:24:04
6:24:06
6:24:08
6:24:10
6:24:12
6:24:14
6:24:16
6:24:18
6:24:20
6:24:22
6:24:24
6:24:26
6:24:28
6:24:30
6:24:32
6:24:34
6:24:36
6:24:38
6:24:40

PM
PM
PM
PM
PM
PM
PM
PM
PM
PM
PM
PM
PM
PM
PM
PM
PM
PM
PM
PM
PM
PM
PM
PM

Left Actigraph
10.3
1.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3.7
0.9
0
0
0
0
0
0

Right Actigraph
0
0
0
0
4.7
0.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.3
0.3
0
0

left leg, there would be movement logged on the right actigraph
exactly eight seconds (or four 2-second epochs) later.

The

duration of the delay was highly consistent within subjects, but
not at all consistent across subjects, ranging from 2 seconds to
just over 30 seconds.

The duration of delay could not be

determined for those participants with almost no movement
activity or those with a significant amount of movement
activity, because it was not possible to identify a consistent
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Table 13.
Time
6:23:54
6:23:56
6:23:58
6:24:00
6:24:02
6:24:04
6:24:06
6:24:08
6:24:10
6:24:12
6:24:14
6:24:16
6:24:18
6:24:20
6:24:22
6:24:24
6:24:26
6:24:28
6:24:30
6:24:32
6:24:34
6:24:36
6:24:38
6:24:40

PM
PM
PM
PM
PM
PM
PM
PM
PM
PM
PM
PM
PM
PM
PM
PM
PM
PM
PM
PM
PM
PM
PM
PM

trend for the delay.

Sample Recoding of Actigraph Output
Left
Actigraph
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
0
0
0
0
0

Right
Actigraph
0
0
0
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
0

Both
Actigraphs
1
1
0
0
1
1
0
0
0
0
0
0
0
0
0
0
1
1
0
0
1
1
0
0

There was no “correction factor” that

could be consistently applied either individually or across
participants to offset this technical problem
After this delay was identified, the company that developed
the ActiTrac monitors was contacted and provided the data.

The

technical support personnel indicated that there was a flaw with
the software used to set the actigraphs to begin recording at
the same time.

Even when new software was obtained, the
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Table 14.

Sample Recoding of Pilot Subject Movements

Time
14:37:02
14:37:04
14:37:06
14:37:08
14:37:10
14:37:12
14:37:14
14:37:16
14:37:18
14:37:20
14:37:22
14:37:24
14:37:26
14:37:28
14:37:30
14:37:32
14:37:34
14:37:36
14:37:38
14:37:40
14:37:42
14:37:44
14:37:46
14:37:48

Left
Actigraph
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
0
0
0
0
0

delay was still apparent.

Right
Actigraph
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
0
1
1
1
0
0
0
0

Both
Actigraphs
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
0
0
0
0

During further communication with the

developers of this device, it became clear that the ActiTrac had
not been designed to be accurate down to the exact second.
Testing after the completion of the study identified the source
of the delay and is described in the discussion section.
Because of the inability of the ActiTrac to log movements
at the exact point of time that the movement occurs, using the
results from both actigraphs would greatly inflate the number of
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2-second epochs in which movements were identified.
Consequently, subsequent analyses are based on the use of one
actigraph.
Because the actigraphs were not logging movements at
exactly the same time relative to each other, it could no longer
be assumed that the actigraphs were logging movement at the
exact same time as the EMG recording.

Recordings were taken

from both the actigraph and tibialis EMG simultaneously in order
to compute exact agreement between these two recording methods.
Though the variable recording delay rendered this statistic
invalid, and it would have been ideal to perform this
calculation, this problem did not represent a major limitation
to the current study as long as the actigraphs were still
capable of documenting movement activity, as they were.

While

it was impossible to perform Kappa for exact agreement between
these recording methods, it did not interfere with calculating
the ability of the actigraphs to distinguish between RLS and
control subjects, which is discussed later.

Instead of

computing Kappa for exact agreement, a Pearson correlation could
still be computed between the total number of two-second epochs
with movement identified by the EMG recording versus the number
of two-second epochs with movement identified by the actigraph
recording to provide some documentation of the association
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between these recording methods.

There was a significant

positive correlation (r=0.7, p<.001) between these two indices.
The original research plan was to perform analyses based on
the number of actual discrete movements.

The latter proved

impossible because the most frequent output from the actigraph
is whether or not there was any movement in a given two second
period.

This is a limitation of the actigraph when compared to

the continuous recording of EMG activity.

A number of the

movements occurred in close proximity, which is easy to
distinguish on the EMG recording, but not in the actigraph
output.

Figure 2 provides an illustration of this finding.

Note in the figure that the EMG recording clearly documents
multiple, discrete movements.

In reviewing the actigraph

output, it is impossible to distinguish between multiple
movements in close proximity versus one or two long movements.
However, there was an important benefit of using two-second
epochs as the outcome measure.

Counting the number of movements

does not take into account the duration of a movement, which is
approximately accounted for when counting each 2-second time
period with movement activity.

Thus, each method has its

advantages and limitations, and either one can address the
experimental hypotheses of this investigation.
Additionally, one of the proposed advantages of developing
an actigraphic method for objectively identifying persons with
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RLS was that it would be faster and require less staff time than
an EMG evaluation.

However, attempting to count discrete

Actigraph

EMG

2 seconds

= 2-second epoch with movement on actigraph
Figure 2.

Comparison of EMG and Actigraph Recording using 2second epochs

movements on the actigraph output as originally planned actually
would have required more time than counting movements based on
the EMG recording.

Fortunately, changing the outcome measure to

number of 2-second epochs with movement, as required by the
limitations of the ActiTrac, turned out to be significantly
faster than examining the EMG recording.
Test of the Experimental Hypothesis
Differentiating RLS from Normal Subjects.

To examine the

diagnostic utility of a measure such as the SIT, there are a
number of statistics that can be computed.
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The performance of a

test can be quantified in terms of its sensitivity, specificity,
positive predictive power, negative predictive power, and the
overall correct classification rate.

Following is a description

of how each of these terms is defined and was calculated for the
current study, based on Kessel and Zimmerman (1993).

Appendix A

provides the computational formulas employed.
Before these statistics were computed, there was an
important consideration: What cutoff score should be employed to
determine whether an individual’s results were consistent with,
or diagnostic of, RLS or not?

In determining whether or not an

individual has a condition or not on the basis of a continuous
variable, in this case the number of 2-second epochs with
movement activity during the SIT, the sensitivity and
specificity of the measure would depend on where the cutoff
between a positive and negative test result was set.

One method

utilized to display the association between sensitivity and
specificity for tests that have continuous outcomes is with
receiver operator characteristic curves (ROC curves).

ROC

curves plot the sensitivity against specificity minus 1.

ROC

curves also provide a useful means of comparing two diagnostic
tests.
The ROC curve was plotted for the actigraph to determine
the cutoff score that would result in the highest combination of
sensitivity and specificity that could be used to determine
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whether an individual’s SIT results were consistent with RLS or
not (see Figure 3).

The ROC curve test statistic indicated that

the cut-off score that should be employed to maximize
sensitivity and specificity was 82 two-second epochs with
movement/hour.

The reference line illustrates a test that is no

better than chance.

The closer an ROC curve is to the upper

left-hand corner of the graph, the more accurate it is, because
the sensitivity and specificity approach 100%.

Complete

detailed explanations of the use and meaning of ROC curves are
have been published (e.g., Begg, 1991; Hanley & McNeil, 1982;
Hanley & McNeil, 1983; Thompson & Zucchini, 1989).
The corresponding sensitivity, specificity, false-positive rate,
false-negative rate, positive predictive value, and negative
predictive value calculated given this cut-off score are
detailed in Table 15.

Sensitivity is the ability of a test to

accurately identify individuals who have a condition as having
the condition.

For the present study, sensitivity was60% and

was computed by dividing the number of RLS patients accurately
identified by actigraphy (i.e., true-positives) by the total
number of RLS patients.

Specificity is the ability of a test to

accurately identify those who do not have the condition as not
having the condition (i.e., true-negatives).

Specificity was

73% and was computed by dividing all of the control subjects
identified as not having RLS by the total number of controls.

42

Sensitivity

1.0
0
.75
Reference
Line
Actigraph

.50
.25
0
0.0
0

.25

.50

.75

1.0
0

1 - Specificity

Figure 3.

ROC Curve Based on Actigraph

False-negatives are the number of individuals incorrectly
identified as not having the condition.

In the present study,

the false negative rate was 40% and was computed by dividing the
number of individuals incorrectly identified as not having RLS
by all subjects with a positive test result.

The false-positive

rate is the number of individuals incorrectly identified by the
test as having a condition.

There was a 27% false positive

rate, which was computed by dividing the number of participants
incorrectly identified as having RLS by all of the subjects with
positive results.
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Table 15. Test Characteristics of the SIT Using Number of 2Second Epoch with Movement on Actigraph Recording
Test

Diagnosis
Positive
Negative

Positive

9

Negative

6

A B
C D

4
11

True Positive/Sensitivity = 60%
True Negative/Specificity = 73%
False Positive = 27%
False Negative = 40%
Positive Predictive Power = 69%
Negative Predictive Power = 65%
Overall Correct Classification = 67%
Valid if (9/4)> (6/11); Actigraphic SIT
valid
Test is effective only if base rate is > 33%
-Screening: 5% is not > 33%; Not
effective for screening
-Clinical: 9% is not > 33%; Not
effective for use in clinical setting
The positive predictive value of a test indicates the
probability that an individual will be correctly identified as
having a condition, given a positive indication on the test.

In

the present study, it was computed by dividing all of the truepositives by all individuals with positive test results.

The

negative predictive value of a test indicates the probability
that an individual will be correctly identified as not having a
condition, given a negative test result.

It was computed in the

present study by dividing the number of true-negatives by all
subjects with negative results.

The positive predictive value

and negative predictive value were 69% and 65% respectively.
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Last, the overall accuracy, or overall correct
classification rate, refers to the proportion of individuals
correctly identified as having a condition or not.

This was

computed by dividing the combined total of true-positives and
true-negatives by the total number of tests performed.

Two

thirds of the participants (67%) were correctly classified using
actigraphy.
An additional factor was considered before making a final
determination as to the usefulness of the actigraphic SIT to
discriminate between those with RLS and controls.

Specifically,

the base rate of RLS, and how that related to the utility of the
SIT as a diagnostic test, was examined.

Thorough explanations

of the association between base rates the interpretation of a
test result has been published (e.g., Gouvier, Hayes, Smiroldo,
1998; Hayes, Hilsabeck, Gouvier, 1999; Pinkston, 1998).

Base

rates refer to the current population prevalence of a condition,
and can be determined by dividing the number of persons with the
condition by the number of persons in the population of
interest.

In other words, base rate is the prior probability

that an individual has a specific condition, regardless of the
outcome of a test.

A test is considered a valid indicator if

the sensitivity (60%) divided by the false positive error rate
(27%) is greater than the false negative error rate (40%)
divided by specificity (73%).

The actigraphic SIT was found to
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be valid (see Table 15).

However, a test is not considered

effective unless the classification rate of the test is superior
to classification based on base rates alone.

In order for a

test to be an effective tool for a clinician, the combined error
rates of the test (i.e., false positive rate plus false negative
rate) should be less than the base rate of the condition.
Otherwise, a clinician would be more accurate overall in making
judgments using base rates alone.

This description applies only

when the base rate of the condition is less than 50%, as with
the current study; an alternate formula is utilized when the
base rate exceeds 50%.
The effectiveness of a test can depend on the base rate
employed.

For example, if one were interested in using the SIT

test as a screening tool to evaluate all persons in the
population for RLS, you would use population prevalence as the
base rate.

Current prevalence studies indicate that RLS exists

in approximately 5% of the population.

On the other hand, if

you want to evaluate effectiveness of the SIT test as a
diagnostic test on persons presenting to a sleep laboratory, one
would use the prevalence of RLS among those presenting to the
sleep laboratory.

There are no published data indicating the

prevalence of RLS in persons presenting to sleep laboratories.
However, a review of 100 sequential referrals to the Baton Rouge
General Medical Center Sleep Disorders Center indicated a
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prevalence or base rate of 9%.

Thus, the effectiveness of the

SIT test was computed using both of the identified base rates to
evaluate the effectiveness of this test for each purpose. Given
the combined error rates for the SIT (33%), the test was not
found to be effective for either screening (assuming 5%
prevalence) or for use clinically (assuming 9% prevalence).
To examine this possibility, all of the test
characteristics were recomputed using number of PLMs as the
dependent variable for the SIT.

ROC curves were completed,

which indicated a cutoff of 2 PLMs/hour provides the greatest
combined sensitivity and specificity.

The calculated test

characteristics are shown in Table 16.

There were a few

differences when using PLMs rather than the number of 2-second
epochs on the actigraph.

The specificity declined slightly due

to one less control being accurately identified, decreasing the
overall correct classification slightly to 63%.

Similar to the

result using actigraphy recordings, this measure did not prove
to be effective for either a screening or a diagnostic tool.
As an additional means of comparing the EMG recording to
the actigraph recording, these test characteristics were
computed using the total number of movements identified on the
EMG recording, using a cutoff score of 17 movements/hour
obtained with an ROC curve.

The results are shown in Table 17.

The sensitivity and specificity improved slightly due to one
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Table 16.

Test Characteristics of the SIT Using Total PLMs
Based on EMG Recording
Diagnosis
Positive
Negative

Test
Positive

9

Negative

6

A B
C D

5
10

True Positive/Sensitivity = 60%
True Negative/Specificity = 67%
False Positive = 33%
False Negative = 40%
Positive Predictive Power = 64%
Negative Predictive Power = 63%
Overall Correct Classification = 63%
Valid if (9/5)> (6/10); EMG SIT using PLMs valid
Test is effective only if base rate is > 37%
-Screening: 5% is not > 37%; Not effective
for screening
-Clinical: 9% is not > 37%; Not effective
for use in clinical setting
additional control and RLS participant being accurately
identified, increasing the overall correct classification
slightly to 70%.

The ROC curves for each of these three

possible outcome measures can be visually compared using Figure
4.
Last, the diagnostic classification status indicated by the
actigraph versus the EMG recording was compared and the Kappa
statistic was calculated to indicate the agreement between these
two measures.

The Kappa value was moderate, though

statistically significant from zero (0.4, p<.05).
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Table 17.

Test Characteristics of the SIT Using Total Movements
Based on EMG Recording
Diagnosis
Positive
Negative

Test
Positive

10

Negative

5

A B
C D

4
11

True Positive/Sensitivity = 67%
True Negative/Specificity = 73%
False Positive = 27%
False Negative = 33%
Positive Predictive Power = 71%
Negative Predictive Power = 69%
Overall Correct Classification = 73%
Valid if (10/4)> (5/11); EMG SIT valid
Test is effective only if base rate is > 27%
-Screening: 5% is not > 27%; Not
effective for screening
-Clinical: 9% is not > 27%; Not effective
for use in clinical setting

Sensitivity

1.0
0
.75

Reference Line
PLMs on EMG

.50

Movement on EMG
Actigraph

.25
0
0

.25

.50

.75

1 - Specificity

Figure 4.

1.0
0

Comparison of ROC Curves
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DISCUSSION
Due to unexpected technical limitations of the actigraph
recordings, an index of exact agreement (i.e., moment-to-moment,
Kappa) between tibialis EMG and actigraphy measures was not
possible, though a more general index of agreement (i.e.,
Pearson) was possible.

There was a statistically significant

positive correlation between EMG and actigraph measures of
movement.

The described technical problem, which appeared to be

a variable recording initiation lag (across subjects), led to
systematic testing of several factors, such as changes in the
intensity and duration of movements, as well as changes in the
initialization process of the two ActiTracs utilized in the
current study, to find any possible explanation for the “delay”.
Initializing the actigraph involves plugging a specialized
cable provided with the devices (connected to a port in a
computer) into the actigraph and starting the device’s software
program.

The program provides the experimenter the opportunity

to set the output frequency of the device, delineate a name for
the file that will be generated, and to set a delayed recording
time if desired.

The user’s manual for the ActiTracs used in

the current study states that after the initialzation process is
completed for a unit that has a delayed recording time
specified, that the unit “will go to ‘sleep’ until the specified
date and time, at which time it will ‘wake up’ and begin
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recording”.

Given this information, the experimenter had

initialized the ActiTracs to each delay the recording time, but
with the same specified future time.

For example, if a SIT was

to begin at 6:30 p.m., the experimenter initialized the first
actigraph with setting a delayed recording time at 6:30 p.m.,
disconnected the first device, and then initialized the second
actigraph with the same delayed recording time (6:30 p.m.).

The

actigraphs were taped to a small board; the experimenter
simulated activity by moving the board.

Attempts were made to

characteristics about the simulated movements, such as the speed
of a simulated movement (e.g., short, slow movements; short,
rapid movements; long, fast movements), as well as the interval
between the simulated movements.
The test data revealed that the ActiTracs were not properly
delaying the beginning of the recording to correspond to the
time specified by the user.

The ActiTracs were in fact

beginning recording at the end of the initialization process,
not at the programmed start time.

The time of completion of the

initialization process was different between the two actigraphs
(as only one could be initialized at time), which accounts for
the different “delay” across participants.

The problem was

tested by varying the interval between the completion of the
initialization process and the delayed start time, with short
periods of activity subsequently simulated on the actigraph, and
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the time the actigraph logged those movements noted.

For

example, on one test trial, the initialization was done at
7:18:44 pm, the start time specified for 7:20:00 p.m., and the
first test movement done at 7:20:10 p.m., the ActiTrac logged
this movement at 7:21:26 p.m., 1 minute 16 seconds later than it
actually occurred.

The time between initialization and the

actual movement was 1 minute 16 seconds, but the time between
the programmed (and actual) start time and the movement was only
10 seconds.

The data thus show that the ActiTrac began

recording at the time of initialization instead of the
programmed time, but labeled that initial epoch as the
programmed start time; this means that the data included the
time between initialization and the programmed start time (the
start of the SIT), when it should have only included data from
the programmed start time and the start of the SIT (actually,
the same time).

Hence the delay. This outcome was repeatedly

found over 8 independent test trials on each of the two
ActiTracs used in this investigation.
Testing also evaluated if the ActiTracs were logging the
duration of movements accurately, if they were properly logging
the interval between movements, and what intensity of movement
was necessary to be logged.

During the 16 test trials (8 for

each ActiTrac), movements of duration varying between 1-10
seconds were simulated.

Each time a movement was simulated, the
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duration and clock time at the start of the simulated movement
was noted.

The interval between simulated movements was also

varied from 10-60 seconds.

The notations were then compared to

the duration of movements and interval between movements
identified on the actigraph output.

Testing revealed that the

movements were being logged at the accurate time (from the time
of initialization), were being logged for the approximate
duration consistently, and consistently logged the intermovement interval.

For example, on trials in which a 6 second

movement was simulated, the actigraph output consistently showed
either three or four two-second epochs with movement (the
approximate agreement due to such factors as human reaction
time).

Also, attempts were made to alter other characteristics

about the simulated movements, such as the speed of a simulated
movement (e.g., short, slow movements; short, rapid movements;
long, fast movements).

It proved difficult to simulate a

movement that the actigraph would not log.

In other words, the

actigraphs appeared to be sensitive enough to pick up a wide
range of intensity of movements.
The above described technical problems with programming a
delayed start support the decision that statistics such as Kappa
would not have been appropriate, as the units were truly not
beginning to record at the same time, despite the output
indicating they were doing so.

Obviously there is a flaw in the

53

software used to initialize the actigraphs.

The beginning

portion each participants recording time, therefore, corresponds
to differences in the time to set up the equipment (i.e.,
initialize the actigraph).

Given the relatively small delays

identified (when the delay could be identified) this would
unlikely result in significant changes in the current findings.
However, clearly future studies such as this should not be
undertaken until the true nature of the actigraphy is better
tested to ensure it’s validity.
There was significantly more movement during the SIT than
activity meeting PLM criteria.

It initially appeared that

previous studies using only PLM activity were too limiting
(Brodeur et al., 1988; Pelletier et al., 1992; Montplaisir et
al., 1998); evaluation of test characteristics showed that this
index was neither too limiting nor additionally beneficial.

In

other words, using a count of the PLMs during the SIT was no
better or worse than using all movement activity.

One of the

PLM criteria in particular, a maximum duration of 4 seconds,
would result in several of the longer voluntary movements not
being counted.

However, the analyses of subsequent test

characteristics did not indicate that an actigraphic SIT would
be an effective diagnostic tool for either screening or clinical
purposes, either when all movement activity was counted, when
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PLM activity only was counted, or when tibialis EMG was used
instead of actigraphy.
Surprisingly, many of the persons with RLS who ultimately
participated in this study had never heard of this disorder.
Only 2 of the 15 RLS participants (13%) knew of RLS prior to
participating in the current study, even though 5 of the
participants had sought treatment for their symptoms previously
and 8 had had a sleep study previously.

Only 1 of the 5

participants who sought treatment specifically for symptoms
consistent with RLS were properly identified as having RLS.
Physicians do not appear to be identifying RLS, which is a
significant public health education issue.

In addition,

inadequate recognition of RLS has significant implications for
previously estimated prevalence rates of RLS.

Overall, studies

examining the prevalence of RLS in the general population have
found that the population prevalence of RLS is approximately 5%.
Recent studies have indicated that the prevalence may be as high
as 15% (Lavigne & Montplaisir, 1994), though some studies have
estimated prevalence on the basis of a single telephone survey
question.

Clearly one isolated question would not provide

adequate evidence of whether or not a person has RLS, which to
be properly diagnosed requires multiple indicators.

As most of

the participants had not been identified as having RLS prior to
enrolling in the current study, the need for public education is
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evident, and the possibility that the 5% rate used in the
current study underestimates the actual prevalence rate of RLS
must be considered in interpreting the clinical utility of the
findings.
The current study does not support the clinical use of an
actigraphic SIT using the methodology described.

In fact, the

sensitivity and specificity found in the current study is
somewhat lower than that found by Montplaisir and fellow
researchers (1998), who also examined the diagnostic utility of
the SIT using polygraph EMG recordings.

Many of the initial

studies examining the SIT were testing the utility of a
particular medication to treat RLS (e.g., Brodeur et al., 1988).
Persons with RLS seeking medical treatment are likely in the
severe range, though most studies do not report any indicators
of symptom severity, such as frequency of symptoms.

The current

study recruited participants from the entire range of symptom
severity.

While this sample would better allow for evaluating

the SIT as a diagnostic and screening tool, it is also likely
the key reason the SIT proved less discriminating than in prior
research.

The possibility of an actigraphic SIT to objectively

measure RLS symptomatology should not be ruled out; changes in
SIT procedures and actigraph outcome variables may be all that
is needed to attain an effective actigraphic SIT, regardless of
symptom severity.

Additionally, the current study utilized one
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outcome measure to discriminate between RLS and control
participant; future studies could examine other objective and
subjective variables in combination with SIT outcome would
improve on the sensitivity and specificity found in the current
study.

Also, the cutoff score utilized in the current study did

provide for the highest combined sensitivity and specificity.
The cutoff score employed could be altered to maximize
sensitivity (i.e., accurately identify a larger proportion of
RLS persons), if one were willing to accept a higher rate of
false positives.

For example, this practice could lead to a

tiered approach in a screening process in which a larger
proportion of persons could be initially identified as possibly
having RLS (likely including the majority of people who truly
have RLS) by using a lower cutoff score, which could be then
followed up by interviewing to exclude higher rate of false
positives that would be generated by the use of a lower cutoff
score.
One possible alteration in SIT procedures that could be
evaluated in future studies would be whether or not establishing
a standardized recording time in the evening would enhance the
diagnostic accuracy of the test.

The latter would capitalize on

the worsening of symptom severity experienced in the evening by
most persons with RLS.

Additionally, given the variable nature

of RLS, these participants may not experience symptoms on the
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day a single SIT is performed.

It is possible that performing

serial SITS would capture at least one or more days of symptom
activity, and using the combined information would allow for
superior discrimination over controls, who would not be expected
to have significant day-to-day changes in SIT outcome.
Advancements in actigraph technology may also correct some
of the problems encountered.

It would be beneficial if

actigraphs were capable of providing output on a frequency
greater than every 2 seconds, which would make it easier to
identify and count discrete movements and would more closely
approximate EMG recording.

Last, it would be useful to evaluate

changes in the directions for the SIT.

Some of the RLS

participants did not have much movement activity.

During

discussion afterwards, some such participants indicated they did
not have symptoms during the SIT; however, others reported that
they were uncomfortable but were able to exert significant selfcontrol over their movements and thus limited their movement
activity despite their discomfort.

Changes in the standard

instructions could reduce the likelihood that lack of movement
is due to the ability of an individual to resist movement even
while withstanding significant discomfort.
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APPENDIX A:

COMPUTATIONAL FORMULAS FOR EVALUATING TEST
CHARACTERISTICS

Test

Diagnosis
Positive
Negative

Positive

A

B

Negative

C

D

True Positive/Sensitivity = A/ (A + C)
True Negative/Specificity = D/ (B + D)
False Positive = B/ (B + D)
False Negative = C/ (A + C)
Positive Predictive Power = A/(A + B)
Negative Predictive Power = D/(C + D)
Overall Correct Classification = (A + D)/N
Valid = (A/B)> (C/D)
Effective if base rate > (B + C)/N
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APPENDIX B:

CONSENT FORM

1.

Study Title:
Use of actigraphy in restless legs syndrome

2.

Performance Sites:
Louisiana State University, Audubon Hall

3.

Contacts:
The following investigators are available for
questions at the phone numbers listed below.

4.

5.

Investigators:
William F. Water

Phone Number:
225-578-8745

Tai A. Istre

504-568-3068

Times Available:
Monday 10-1;
Tuesday 10-5
Monday-Friday, 9-5

Purpose of the Study: The goal of the current study is to
evaluate whether two different tests can assess leg muscle
activity the same. The tests being used in the study may
help in diagnosing individuals with a sleep disorder called
restless legs syndrome.
Subjects:
A. Inclusion Criteria: Subjects must be at least 18 years
old to participate. In order to be included, participants
must meet criteria for restless legs syndrome or must be
close in age to a participant who has restless legs
syndrome.
B.

Exclusion Criteria:

Persons younger than 18 years old.

C.

Maximum number of subjects: 30

6.

Study Procedures: All participants will be asked to provide
descriptive information such as their age, gender, and
symptoms of restless legs syndrome. During the study,
participants will be need to stay awake, sit on a bed with
their legs outstretched, and to keep their eyes open while
attempting to remain completely still for 60 minutes. Each
participant will have four electrodes placed on their lower
leg, two on each leg, which will measure how much they move
their legs. Participants will also have an actigraph (a
small device that looks like a wrist watch) placed on each
ankle, which will also measure how much they move their
legs. The study will take approximately one and a half
hours to complete.

7.

Benefits: The study will not benefit subjects directly. The
current study may provide an easy test that would be helpful
in diagnosing Restless Legs Syndrome in the future.
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8.

Risks/Discomforts: The risks are very small, and include a
small possibility of developing mild skin irritation where
recording devices are attached to the skin. Persons with
Restless Legs Syndrome who withdraw from medications being
used to treat their disorder may have a return of their
symptoms the day they abstain from their medication.
Participants may experience discomfort while attempting to
keep their legs completely still. Though participants will
be asked to keep as still as possible, they can move their
legs if necessary to help decrease any discomfort.

9.

Measures taken to reduce risk: Participants who will be
abstaining from their medications related to their Restless
Legs Syndrome will be doing so under the supervision of
their physician.

10.

Right to Refuse: Participation in the study is voluntary
and participants may change their mind and withdraw from the
study at any time without penalty.

11.

Privacy: The results from the study may be published as
group data in which no subjects’ results are presented
individually. The privacy of participating subjects will be
protected and the identity of participants will not be
revealed. The data collected will not be used for any
purpose not approved by the participants and the LSU
Institutional Review Board.

12.

Financial Information: There will be no monetary
compensation for participation in the study.

13.

Withdrawal: Participants may withdrawal from the study at
any time by telling the investigator at any time.

14.

Removal:
Restless Legs Syndrome participants who do not
abstain from medication prescribed for the treatment of
this condition or who do not obtain written permission from
their doctors to do so will not be able to participate.

15.

Signatures: The study has been discussed with me and all
my questions have been answered. I may direct additional
questions regarding study specifics to the investigators.
If I have questions about subjects' rights or other
concerns, I can contact Robert c. Mathews, Chairman, LSU
Institutional Review Board, (225)578-8692. I agree to
participate in the study described above and acknowledge
the researchers’ obligation to provide me with a copy of
this consent form if signed by me.

_______________________Participant Signature ____________ Date
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_______________________Witness Signature _____________ Date
_______________________Investigator Signature ___________ Date
The study subject has indicated to me that he/she is unable to
read. I certify that I have read this consent form to the subject
and explained that by completing the signature line above, the
subject has agreed to participate.
_______________________Signature of Reader ___________ Date
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APPENDIX C:

RESTLESS LEGS SYNRDOME QUESTIONNAIRE

1. Do you ever have uncomfortable sensations in your legs?
 Yes
 No (if not, skip to question #24)
2. Please describe the sensations in your legs as best you can:

3. At what times do you get the symptoms?

4. Do your symptoms get worse in the evening or night?
 Yes
 No
5. What do you do when you get the symptoms?

6. Does physical activity decrease or relieve you symptoms?
 Yes
 No (if not, you make skip to question #8)
7. Which of the following activities are helpful in relieving
your symptoms? (check all that apply)
 Rubbing or massaging your legs
 Moving your legs
 Using a heating pad or taking a warm or hot bath
 Applying anything cold to the legs
 Stretching your legs
 Getting up and walking around
 Other (please describe):
_______________________________________________
8. How old were you when you first began to get the symptoms?
_________ years old
9. Have there been periods of time when the symptoms got better
or worse or even went away completely? Describe.
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10. Are there any things that seem to make your symptoms better
or worse? Please describe.

11. Are your symptoms worse when you are under stress?
 Yes
 No
12. How often have you had the sensations in your legs over the
past 6 months?
 One or two nights a week
 Three or four nights a week
 Five or six nights a week
 Every night of the week
13. Do you also get the sensations in your legs during the day?
If yes, please note how often you have had them over the last
6 months.
 One or two days a week
 Three or four days a week
 Five or six days a week
 Every day of the week
14. Please use the list below to indicate
occur? (check all that apply)
 Feet
 Lower legs (between the ankle and knee)
 Thighs
 Groin
 Trunk

where the sensations






Shoulders or neck
Upper arms
Forearms
Hands or fingers

15. Are your symptoms worse on one side?
 No, it is the same on both side of my body
 Yes, the symptoms are worse on the left side
 Yes, the symptoms are worse on the right side
16. Use the rating scale below to indicate how severe your
restless legs symptoms usually are:
1
2
3
4
5
6
7
Mild
Severe
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17. Do you have difficulty falling asleep because of your
symptoms?
 Yes
 No
18. When you experience symptoms of restless legs, how long
does it take you to fall asleep (on average)? ___________ min.
19. When you do not experience symptoms of restless legs, how
long does it take you to fall asleep (on average)?
_______________ minutes
20. Have you ever sought treatment for you symptoms of restless
legs?
 Yes
 No (skip to question #22)
21.

What treatment or medication did your doctor prescribe?

22.

How effective was the treatment?

23. Have you ever had a sleep study (Polysomnogram) done?
 Yes
 No
24.

What is your date of birth?

25. Gender:
 Male
 Female
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